Related Experiment Video
Updated: Aug 9, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells
1Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231.
Insights
Interferon-alpha (IFN-alpha) significantly inhibits human immunodeficiency virus type-1 (HIV-1) replication by blocking provirus formation. This antiviral effect stems from IFN-alpha interfering with the initiation of HIV-1 reverse-transcription.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Interferon-alpha (IFN-alpha) is known to inhibit human immunodeficiency virus type-1 (HIV-1) replication in cell lines.
- The precise mechanism of IFN-alpha's antiviral activity against HIV-1 requires further elucidation.
Purpose of the Study:
- To investigate the specific stage at which IFN-alpha inhibits HIV-1 replication.
- To determine if IFN-alpha affects provirus formation and reverse-transcription.
Main Methods:
- Polymerase chain reaction (PCR) was used to detect HIV-1 proviral DNA in infected cells.
- Primers were designed to detect complete or nearly complete proviral DNA and early reverse-transcripts.
- In vitro assays were performed using cytoplasmic extracts from IFN-alpha-treated cells to assess reverse transcriptase activity.
Main Results:
- IFN-alpha pretreatment significantly reduced the levels of HIV-1 proviral DNA in infected cells.
- IFN-alpha was found to interfere with the initiation of HIV-1 reverse-transcription.
- Cytoplasmic extracts from IFN-alpha-treated cells inhibited HIV-1 reverse transcriptase activity in vitro.
Conclusions:
- IFN-alpha inhibits HIV-1 replication by blocking provirus formation at the level of reverse-transcription initiation.
- IFN-alpha demonstrates therapeutic potential for limiting the spread of HIV-1 infection.
Abstract:
Previously, we have shown that interferon (IFN)-alpha markedly inhibits human immunodeficiency virus type-1 (HIV-1) replication in the CEM-174 lymphocytic cell line during a single replication cycle. In the present study, we demonstrate that the IFN-mediated block of HIV-1 replication is at the level of HIV-1 provirus formation. Using polymerase chain reaction and a set of primers that detects complete or nearly complete proviral DNA, HIV-1 provirus could be found as early as 5 hr after infection in CEM-174 cells and peripheral blood lymphocytes. Pretreatment of cells with 500 U/ml IFN-alpha resulted in a significant reduction in the relative levels of HIV-1 proviral DNA. The levels of HIV-1 proviral DNA in IFN-alpha-treated cells were also reduced when primers detecting the early reverse-transcripts were used, indicating that IFN interferes with the initiation of HIV-1 reverse-transcription. The inhibition of provirus formation was also observed in vitro; addition of cytoplasmic extracts from IFN-treated CEM-174 cells, but not from the control cells, resulted in inhibition of both virion-associated and recombinant HIV-1 reverse transcriptase activity. These studies implicate that, when used therapeutically, IFN-alpha should limit the spread of HIV-1 infection.
More Related Videos
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viruses with RNA Genomes
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly